HHS challenges Vertex Pharmaceuticals' fertility services program, alleging violations of anti-kickback laws linked to its ...

It can generate billions in revenue from both acute and possibly chronic pain. If approved, it would give Vertex ...

After Vertex President and CEO Reshma Kewalramani presented at the firm’s healthcare conference, JPMorgan analyst Jessica Fye notes that the ...

J.P. Morgan analyst Jessica Fye has maintained their bullish stance on VRTX stock, giving a Buy rating today.Stay Ahead of the Market:Discover ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 10:30 AM ETCompany ParticipantsDr.

While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor ...

A new treatment for cystic fibrosis has been approved by the U.S. Food and Drug Administration (FDA).

Vertex Global Services partners with UK-based Arish Global Services to create over 5,000 jobs in India, boosting the outsourcing sector and providing new career opportunities in emerging technologies.

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...